Imagine Pharma LLC is a biotechnology company that develops novel polypeptide-based platforms focused on oral delivery for biologic drugs, therapeutics for various disease states, and regenerative medicine. The company aims to create first-in-class treatments for conditions such as diabetes and wound healing, alongside offering oral peptide dietary supplements and functional ingredients for consumers.
Subscribe to see IMAGINE PHARMA LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IMAGINE PHARMA LLC is a biotechnology company headquartered in Pittsburgh, United States. It has raised at least $33.1M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round, Series A, raised $32.5M in October 2023. Xcout tracks 5 named people at IMAGINE PHARMA LLC, including Jonathan Pollett, PhD (Chief Research Officer).
As of 17 November 2026. Source: Xcout Intel.
At least $33.1M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $32.5M | 1 named | |
| SEC Form D filing | $300,000 | — | |
| SEC Form D filing | $350,000 | — | |
| SEC Form D filing | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of IMAGINE PHARMA LLC's closest competitors — see the full list of competitors and alternatives →
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Paulex Bio Inc. is a biotechnology company headquartered in San Diego, California, focused on transformative treatments for type 1 and type 2 diabetes. Its lead approach targets beta cell regeneration through an oral administration.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Inmagene Biopharmaceuticals is a clinical-stage biotechnology company headquartered in San Diego, California. The firm is dedicated to the research, development, and advancement of novel therapeutic medicines. It operates within the life sciences sector, focusing on clinical development and corporate mergers.
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about IMAGINE PHARMA LLC? Suggest a correction · Work at IMAGINE PHARMA LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.